T. Robak et al., 2-CHLORODEOXYADENOSINE (CLADRIBINE)-RELATED EOSINOPHILIA IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES, European journal of haematology, 59(4), 1997, pp. 216-220
Eosinophilia and allergic skin reactions are uncommon events after 2-c
hlorodoxyadenosine (2-CdA, cladribine) administration. A multicentre r
etrospective analysis of eosinophilia in 360 patients treated with 2-C
dA for lymphoid malignancies has been made, B-cell chronic lymphocytic
leukaemia (B-CLL) was diagnosed in 153, hairy cell leukaemia (HCL) in
68, low-grade non-Hodgkin's lymphoma (LGNHL) in 119, high-grade NHL i
n 2 and Waldenstrom's macroglobulinaemia (WM) in 18 patients. 2-CdA wa
s administered al a dose 0.12 mg/kg/d in 2-h intravenous infusion for
5 consecutive d. The courses were repeated monthly Patients with HCL r
eceived 1 cycle of 2-CdA, with NHL 2-6 (mean 3.5) cycles and with B-CL
L 3-6 (mean 5) cycles. Twenty patients (5.5%), including 5 with HCL, 6
with LGNHL, 7 with B-CLL and 2 with WM, developed peripheral blood eo
sinophilia. The mean values of absolute eosinophil count were 0.78x10(
9)/l (0.58-1.06x10(9)/l), 0.71x10(9)/l (0.52-1.3x10(9)/l), 85 (0.56-1.
82x10(9)/l) and 0.75 (0.74-0.76x10(9)/l), respectively. Eosinophilia o
ccurred in 13 patients after 1 course, in 4 after 2 courses, and in 5
after greater than or equal to 3 courses of the therapy. In 17 cases i
t resolved spontaneously, Allergic skin lesions with pruritus were not
iced in 3 patients simultaneously with an increase in eosinophil count
. All of them required antihistaminic drugs and/or corticosteroids, On
e patient with B-CLL experienced repeated episodes of eosinophilia. Th
e highest incidence of 2-CdA-induced eosinophilia was noticed in patie
nts with MW (11.1%) and HCL (7.4%) who received only 1 cycle of this d
rug and entered a complete remission. This side effect was less freque
ntly observed in LGNHL and B-CLL, i.e, in 5.0% and 4.6% of cases, resp
ectively. The mechanism of 2-CdA-induced eosinophilia is not clear. It
has been postulated that massive tumour cell lysis may trigger a rele
ase of IL-5 and probably other cytokines. The allergic mechanism of 2-
CdA-induced eosinophilia is also possible, especially in patients with
simultaneous skin reactions.